Um caso de hiperpermeabilidade capilar
Palavras-chave:
síndrome de hiperpermeabilidade capilar, edema, citocinasResumo
Os autores apresentam um caso clínico de anasarca num homem
de 64 anos com antecedentes de tumor neuroendócrino gástrico
metastizado, em quem foi feito o diagnóstico de síndrome de
hiperpermeabilidade capilar, após exclusão de outras causas de edema.
Segue-se uma revisão das principais causas de edema
generalizado e da etiologia e tratamento da síndrome de hiperpermeabilidade capilar.
Downloads
Referências
Clarkson B, Thompson D, Horwith M, Luckey EH: Cyclical edema and shock due to increased capillary permeability. Trans Assoc Am Physicians 1960; 73:272-282.
Lleonart R, Alonso R, Cisteró-Bahima A: Thirty-four year old woman with generalized oedemas, oligoanuria and hypovolaemic shock. Alergol Immunol Clin 1999; 14:336-342.
Droder RM, Kyle RA, Greipp PR: Control of systemic capillary leak syndrome with aminophylline and terbutaline. Am J Med 1992; 92:523-526.
Stachel D, Schmid I, Lang T, Haas RJ, Otte JB: Double bone marrow transplantation for severe aplastic anemia after orthotopic liver transplantation: implications for clinical management and immune tolerance. Transpl Int 2002; 15:39-44.
Atkinson JP, Waldmann TA, Stein SF, Gelfand JA, Macdonald WJ, Heck LW, Cohen EL, Kaplan AP, Frank MM: Systemic capillary leak syndrome and monoclonal IgG gammopathy; studies in a sixth patient and a review of the literature. Medicine (Baltimore) 1977; 56:225-239.
Vial T, Descotes J: Clinical toxicity of interleukin-2. Drug Saf 1992; 7:417-433.
Walther EU, Hohlfeld R: Multiple sclerosis: side effects of interferon beta therapy and their management. Neurology 1999; 53:1622-1627.
Niederwieser G: Lethal capillary leak syndrome after a single administration of interferon beta-1b. Neurology 2000; 54:1545-1546.
Yamamoto K, Mizuno M, Tsuji T, Amano T: Capillary leak syndrome after interferon treatment for chronic hepatitis C. Arch Intern Med 2002;
:481-482.
Hoffman U, Fontana A, Steurer J, al e: Idiopathic oedema with increased cytokine production: a pathogenic link? Journal of Internal Medicine 1998; 244:179-182.
Zimmermann GA, Prescott SM, McIntire TM: Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today 1992; 13:93-98.
Biswas S, Nik S, Corrie PG: Severe gemcitabine-induced capillary-leak syndrome mimicking cardiac failure in a patient with advanced pancreatic cancer and high-risk cardiovascular disease. Clin Oncol (R Coll Radiol) 2004; 16:577-579.
Pulkkanen K, Kataja V, Johansson R: Systemic capillary leak syndrome resulting from gemcitabine treatment in renal cell carcinoma: a case report. J Chemother 2003;15:287-289.
De Pas T, Curigliano G, Franceschelli L, Catania C, Spaggiari L, de Braud F: Gemcitabine-induced systemic capillary leak syndrome. Ann Oncol 2001; 12:1651-1652.
Ponzinibbio C: [Retinoic acid syndrome]. Medicina (B Aires) 1997; 57:473-485.
Worth LL, Jaffe N, Benjamin RS, Papadopoulos NE, Patel S, Raymond AK, Jia SF, Rodriguez C, Gano J, Gianan MA, et al.: Phase II study of recombinant interleukin 1alpha and etoposide in patients with relapsed osteosarcoma. Clin Cancer Res 1997; 3:1721-1729.
Jillella AP, Day DS, Severson K, Kallab AM, Burgess R: Non-Hodgkin’s lymphoma presenting as anasarca: probably mediated by tumor necrosis factor alpha (TNF-alpha). Leuk Lymphoma 2000; 38:419-422.
Ranzy O, Adour D, Arler P: Chronic systemic capillary syndrome not requiring treatment? Am J Med 1998; 130:905-909
Ficheiros Adicionais
Publicado
Como Citar
Edição
Secção
Licença
Este trabalho encontra-se publicado com a Licença Internacional Creative Commons Atribuição 4.0.
Direitos de Autor (c) 2023 Medicina Interna
Acesso livre
